
About Synokem Lifesciences Private Limited
Data last updated:
Synokem Lifesciences Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Synokem Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2020PTC362777. Its GSTIN is 07ABDCS5598N1ZH (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹180 Cr and a paid-up capital of ₹175.25 Cr. It is led by directors including Abhinav Arora (Managing Director) and Thomas Baby.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block – A 14/486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.46 Cr, a growth of 108% compared to the previous year. For the same year it recorded a net loss of ₹29.55 Cr (net margin -29.7%) and EBITDA of -₹9.68 Cr (EBITDA margin -9.7%). Revenue has grown at a compounded annual rate (CAGR) of 664% over three years.
The company has about 401 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹115 Cr and satisfied charges of ₹19 Cr on record. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020. Its 6 peer companies in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Credo Life Sciences Private Limited with revenue of ₹100.47 Cr. The company has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synokempharma.com.
Company details
Contact details
Synokem Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered AddressBlock – A 14/486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synokem Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synokem Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synokem Lifesciences Private Limited, buy the company report.
Financials of Synokem Lifesciences Private Limited
FY 2025 filings availableSynokem Lifesciences Private Limited reported revenue of ₹99.46 Cr (up 108% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 664% over three years, including 108% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29.55 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.7% | ||||
| Net Profit Margin | -29.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synokem Lifesciences Private Limited, buy the company report.
Board of directors of Synokem Lifesciences Private Limited
Synokem Lifesciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhinav Arora Also directs: SPL Packaging Limited Liability Partnership, Synokem Pharmaceuticals Limited, Kemsyn Lifesciences Private Limited and 2 more | Managing Director | 14 Mar 2020 | 6 Years 8 Months | Current |
| Thomas Baby | Director | 03 May 2022 | 4 Years 6 Months | Current |
| Vishal Gupta | Nominee Director | 18 Jan 2023 | 3 Years 10 Months | Current |
| Shubhangi Agarwal Also directs: Synokem Pharmaceuticals Limited, Agsa and Associates LLP, Ampl Capital Limited and 4 more | Director | 27 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Synokem Lifesciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Credo Life Sciences Private Limited | ₹100.47 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Consern Pharma Limited | ₹100.37 Cr (FY 2025) | -2.0% | Ludhiana, Punjab, India | |||
| Medibios Laboratories Limited | ₹100.12 Cr (FY 2023) | -2.0% | ||||
| Synokem Lifesciences Private Limitedthis company | ₹99.46 Cr (FY 2025) | -₹29.55 Cr | -29.7% | 108.0% | 401 | New Delhi, Delhi, India |
| Claroid Pharmaceuticals Limited | ₹98.31 Cr (FY 2025) | 48.0% | Ahmedabad, Gujarat, India | |||
| Sirmour Remedies Private Limited | ₹98.1 Cr (FY 2025) | -18.0% | Paonta Sahib, Himachal Pradesh, India | |||
| Enicar Pharmaceuticals Private Limited | ₹97.81 Cr (FY 2025) | -1.0% | Boisar, Maharashtra, India |
To see the full peer comparison of Synokem Lifesciences Private Limited, buy the company report.
Auditor
Synokem Lifesciences Private Limited is audited by BSR & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR & Co. LLP | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Synokem Lifesciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Synokem Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2023 | 100791388 | Others | ₹115 Cr | Open | |
| 28 Apr 2022 | 100573857 | Others | ₹19 Cr | Satisfied |
To see the full charge records of Synokem Lifesciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Synokem Lifesciences Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Rights issue | ₹44.99 Cr | Investors: Synokem Pharmaceuticals Limited |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Synokem Pharmaceuticals Limited , Synokem Pharmaceuticals Limited & Abhinav Arora Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Synokem Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Synokem Lifesciences Private Limited has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 105)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Trichem Lifesciences Limited | |||
| Panvo Organics Private Limited | |||
| Abs Packaging Industries | |||
| Shiva Printing and Packaging | |||
| SPL Packaging LLP |
To see the full MSME payment records of Synokem Lifesciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Synokem Lifesciences Private Limited has a workforce of 401 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 401 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Synokem Lifesciences Private Limited, buy the company report.
GST
Synokem Lifesciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABDCS5598N1ZH | Delhi | Active | 18 Jun 2020 |
| 05ABDCS5598N1ZL | Uttarakhand | Active | 27 Dec 2020 |
To see the full GST registrations and return filing status of Synokem Lifesciences Private Limited, buy the company report.
Recent activity
Synokem Lifesciences Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Shubhangi Agarwal was appointed as Director on 27 Nov 2025.
1 earlier event is in the company report.
Frequently asked questions
Synokem Lifesciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 2020 (6+ years old) and is registered under CIN U24230DL2020PTC362777.
Synokem Lifesciences has 4 current directors:
- Abhinav Arora - Managing Director
- Thomas Baby - Director
- Vishal Gupta - Nominee Director
- Shubhangi Agarwal - Director
The latest financial statements of Synokem Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Synokem Lifesciences is 07ABDCS5598N1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05ABDCS5598N1ZL (Uttarakhand).
The CIN (Corporate Identification Number) of Synokem Lifesciences is U24230DL2020PTC362777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synokem Lifesciences was incorporated on 14 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Synokem Lifesciences has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020.
The peers of Synokem Lifesciences by revenue are Credo Life Sciences Private Limited, Consern Pharma Limited, Medibios Laboratories Limited, Claroid Pharmaceuticals Limited, Sirmour Remedies Private Limited and 1 more, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shubhangi Agarwal was appointed as Director on 27 Nov 2025. Abhiruchi Arora ceased to be Director on 01 Feb 2024. Vishal Gupta was appointed as Nominee Director on 18 Jan 2023. Synokem Lifesciences has 6 board changes on record in total.
Synokem Lifesciences has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers. The latest return was filed on 13 May 2024.
Synokem Lifesciences can be reached through the website synokempharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Synokem Lifesciences is at Block – A 14486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087.

